🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

BTIG starts Airsculpt Technologies with a Neutral rating

Published 10/17/2024, 04:36 AM
AIRS
-

On Wednesday, BTIG began coverage on Airsculpt Technologies Inc. (NASDAQ: NASDAQ:AIRS), assigning a Neutral rating to the stock. The firm highlighted AirSculpt as a national provider of body contouring procedures, currently operating 29 centers across the United States and one each in Canada and the United Kingdom. These centers exclusively offer AirSculpt, a minimally invasive procedure designed to remove unwanted fat.

The company has faced challenges over the past year, with mature centers experiencing a decline in case volumes. This trend has been attributed to consumers reducing their spending on medical aesthetics and cosmetic surgery. Despite these headwinds, AirSculpt has managed to mitigate the impact by opening new centers. However, increased marketing expenditures have put additional pressure on the company's profit margins.

BTIG noted the strong unit economics within AirSculpt's business model. The average center generated approximately $7.5 million in revenue with gross margins in the low-60 percent range over the last twelve months. Even with rising customer acquisition costs, the average center reportedly realized around $3 million in profit.

The analysis by BTIG suggests that AirSculpt has the potential for growth, given that it only has 31 active centers and could expand into new markets. Despite the positive aspects of the service model and the opportunities for long-term growth, BTIG's Neutral rating reflects the current economic environment and the uncertain outlook for demand stabilization in the industry.

In other recent news, AirSculpt Technologies has made significant strides in its business operations. The company has expanded its reach with the opening of a new body contouring center in Deerfield, marking its 30th location. This new center will provide the full range of AirSculpt's services and is anticipated to reflect the positive outcomes experienced in their existing Chicago clinic.

In addition to this expansion, AirSculpt has also revised its credit agreement terms, adjusting financial covenants and interest rates. This amendment provides more flexible financial benchmarks and requires the company to maintain a minimum liquidity of $6.75 million and $7.5 million at the end of certain fiscal quarters.

AirSculpt Technologies has also reported a decrease in second-quarter earnings due to challenging demand conditions, leading to a revision of its full-year revenue guidance to between $180 million and $190 million, and adjusted EBITDA to between $23 million and $28 million. In response to these developments, Dennis Dean has stepped in as Interim CEO and CFO. These are the recent developments in the company's operations.

InvestingPro Insights

Recent data from InvestingPro sheds additional light on AirSculpt Technologies Inc.'s financial position and market performance. The company's market capitalization stands at $327.7 million, reflecting its current valuation in the market. Despite the challenges mentioned in the article, AirSculpt has shown impressive revenue growth of 6.58% over the last twelve months, with total revenue reaching $193.03 million.

InvestingPro Tips highlight some interesting aspects of AirSculpt's financial health and market performance. One tip notes that the company's stock price movements are quite volatile, which aligns with the uncertain outlook mentioned in the BTIG analysis. Another tip indicates that AirSculpt has seen a significant return over the last week and a strong return over the last month, with the 1-month price total return reaching an impressive 48.56%. This recent positive momentum could be worth monitoring in light of the challenges described in the article.

It's worth noting that InvestingPro offers 11 additional tips for AirSculpt Technologies, providing a more comprehensive analysis for investors interested in delving deeper into the company's prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.